New tool developed to predict progression of Rheumatoid Arthritis

MBST to treat Rheumatoid arthritis

A new tool has successfully been developed to predict the progression of Rheumatoid arthritis. This could help in the prevention and treatment, as well as give experts a clearer understanding of the disease.

Below, we look at what the research revealed, and how MBST can help to combat and control Rheumatoid arthritis.

What the latest research revealed

The new research, carried out by the Tokyo Medical and Dental University, assessed the effectiveness of a new tool to predict the progression of Rheumatoid Arthritis. A Polygenic Risk Score (PRS) was developed to predict radiographic progression, from data taken from the Genome-Wide Association Study (GWAS).

Genetic factors have been discovered to have an association with the disease in previous studies. However, up until now there hasn’t been a way to accurately predict these factors. In the latest study, summary statistics taken from GWAS were used to develop a PRS. Radiographic joint damage was then evaluated through patient records.

The researchers concluded by carrying out a statistical analysis to determine if a link between the severity of the disease and PRS. A multivariable analysis was performed to assess the association between PRS and other factors, and radiographic progression.

It was discovered that there was a significant difference in the PRS of non-severe and severe progression groups. Patients who were discovered to have a high PRS, were also found to have an increased risk of experiencing severe progression.

The findings could help in the development of more precise medicine approaches within the treatment of Rheumatoid arthritis.

What is Rheumatoid arthritis?

Rheumatoid arthritis is an autoimmune condition that leads to stiffness, pain, and swelling within the joints. It tends to affect more than one joint, and it causes damage to the surrounding tissue. This can lead to deformity, issues with balance, and long-term chronic pain. Many patients experience flare ups of the condition, though treatment can be provided to help ease the symptoms.

The cause of the condition isn’t yet known and there is no cure. The condition is known to affect more women than men, and people who smoke or have a history of Rheumatoid arthritis are at an increased risk.

Using MBST to treat Rheumatoid arthritis

While there is no cure for Rheumatoid arthritis, there are treatments that can help patients to manage the condition. Long term medications can help to slow down the rate of progression, and physiotherapy can aid in mobility. If problems develop in the joint, surgery may also be required to correct them.

MBST is another treatment option that is currently gaining in popularity. This revolutionary treatment has proven to be effective at repairing the cartilage and tissue damaged by arthritis. This ultimately reverses the damage caused by the condition, eliminating pain and improving mobility in patients.

To discover if MBST could be an ideal treatment option to treat your Rheumatoid arthritis, book a consultation with MBST London.